Loading...
XSHE300452
Market cap369mUSD
Jan 08, Last price  
11.64CNY
1D
-0.68%
1Q
-11.75%
Jan 2017
-32.54%
IPO
149.11%
Name

Anhui Sunhere Pharmaceutical Excipients Co Ltd

Chart & Performance

D1W1MN
XSHE:300452 chart
P/E
16.76
P/S
3.23
EPS
0.69
Div Yield, %
2.21%
Shrs. gr., 5y
0.35%
Rev. gr., 5y
14.39%
Revenues
839m
+19.12%
143,233,492183,880,565212,890,537239,393,819258,919,172286,403,295339,358,774428,556,522464,067,090531,196,557616,707,253704,525,235839,259,534
Net income
162m
+23.58%
21,844,99832,162,98135,020,38534,932,45344,272,96948,785,59350,335,76670,109,45884,370,51293,942,64289,253,357130,708,710161,535,015
CFO
143m
+7.54%
026,414,06525,889,31436,827,62142,657,40755,334,01863,512,14374,764,43879,474,81485,551,579103,823,162132,817,316142,836,848
Dividend
May 29, 20240.25 CNY/sh
Earnings
May 16, 2025

Profile

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. manufactures and sells pharmaceutical excipients and professional medicines in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products to Europe, the United States, Southeast Asia, and internationally. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. is based in Huainan, China.
URL
http://www.shanhe01.com/
IPO date
May 15, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
839,260
19.12%
704,525
14.24%
Cost of revenue
649,685
557,731
Unusual Expense (Income)
NOPBT
189,575
146,794
NOPBT Margin
22.59%
20.84%
Operating Taxes
21,197
5,470
Tax Rate
11.18%
3.73%
NOPAT
168,378
141,324
Net income
161,535
23.58%
130,709
46.45%
Dividends
(59,785)
(54,121)
Dividend yield
1.74%
1.32%
Proceeds from repurchase of equity
(602)
(1,210)
BB yield
0.02%
0.03%
Debt
Debt current
9,179
39,843
Long-term debt
287,587
Deferred revenue
35,003
31,125
Other long-term liabilities
1
Net debt
(389,673)
(325,818)
Cash flow
Cash from operating activities
142,837
132,817
CAPEX
(54,922)
Cash from investing activities
(332,978)
(88,207)
Cash from financing activities
228,167
(48,519)
FCF
102,641
37,989
Balance
Cash
685,731
364,684
Long term investments
708
977
Excess cash
644,476
330,435
Stockholders' equity
780,683
724,944
Invested Capital
623,374
527,302
ROIC
29.27%
28.57%
ROCE
14.82%
16.81%
EV
Common stock shares outstanding
241,097
233,408
Price
14.24
-18.72%
17.52
4.00%
Market cap
3,433,222
-16.04%
4,089,315
3.47%
EV
3,112,703
3,829,593
EBITDA
228,641
182,858
EV/EBITDA
13.61
20.94
Interest
4,298
1,213
Interest/NOPBT
2.27%
0.83%